Search

Your search keyword '"van den Akker, E."' showing total 510 results

Search Constraints

Start Over You searched for: Author "van den Akker, E." Remove constraint Author: "van den Akker, E."
510 results on '"van den Akker, E."'

Search Results

3. POS0750 WHO PARTICIPATES IN AN ONLINE SYMPTOM CHECKER? CHARACTERISTICS, ATTRITION AND REPRESENTATIVENESS IN THE RHEUMATIC? STUDY

4. OP0033 FIBROBLAST GENE, FKBP7 INDUCED BY Ca2+DEPENDENT ER STRESS ASSOCIATED WITH CLINICAL OUTCOME IN RHEUMATOID ARTHRITIS AND CROHN’S DISEASE; MULTI-CENTRE GWAS AND FUNCTIONAL STUDIES

5. AB1480 STRATIFICATION OF PATIENTS USING ADVANCED INTEGRATIVE MODELLING OF DATA ROUTINELY ACQUIRED FOR DIAGNOSING RHEUMATIC COMPLAINTS (SPIDeRR): A MULTICENTER EUROPEAN CONSORTIUM

6. Lifestyle factors and metabolomic aging biomarkers: Meta-analysis of cross-sectional and longitudinal associations in three prospective cohorts

7. NMR metabolomics-guided DNA methylation mortality predictors

8. The WHO 2013 oral glucose tolerance test:The utility of isolated glucose measurements - A retrospective cohort study

9. Clinical management of patients with genetic obesity during COVID-19 pandemic: position paper of the ESE Growth & Genetic Obesity COVID-19 Study Group and Rare Endo-ERN main thematic group on Growth and Obesity

11. Endocrinologie

18. Blood pressure (BP) status in Congenital Adrenal Hyperplasia (CAH) – longitudinal analysis of real world data from the I-CAH registry

20. Semi-analytical Solution of the Density Profile for a Gas Close to a Solid Wall

25. Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline

27. Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency:an Endo-ERN clinical practice guideline

28. Modèle d’obésité d’apparition précoce : impact de la réduction précoce du poids sur l’espérance de vie et sur le risque de comorbidités chez un patient atteint d’obésité sévère et précoce

30. Genomics of human longevity

31. Genetics and Not Shared Environment Explains Familial Resemblance in Adult Metabolomics Data

32. Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials

35. Adenotonsillectomy In Children With Mild Symptoms

37. Specific proteome changes in platelets from individuals with GATA1-, GFI1B-, and RUNX1-linked bleeding disorders

39. Specific proteome changes in platelets from individuals with GATA1-, GFI1B-, and RUNX1-linked bleeding disorders

40. The trans-ancestral genomic architecture of glycemic traits

41. The trans-ancestral genomic architecture of glycemic traits

42. Clinical management of patients with genetic obesity during COVID-19 pandemic:position paper of the ESE Growth & Genetic Obesity COVID-19 Study Group and Rare Endo-ERN main thematic group on Growth and Obesity

43. Appetite-and weight-inducing and-inhibiting neuroendocrine factors in prader–willi syndrome, bardet–biedl syndrome and craniopharyngioma versus anorexia nervosa

46. Author Correction: Heritability estimates for 361 blood metabolites across 40 genome-wide association studies (Nature Communications, (2020), 11, 1, (39), 10.1038/s41467-019-13770-6)

Catalog

Books, media, physical & digital resources